Methadone Substitution Is Cost-Effective Option for Addressing HIV Epidemic in Ukraine
March 4, 2011
"Methadone substitution therapy is a highly cost-effective option for the growing mixed HIV epidemic in Ukraine," according to the authors of a PLoS Medicine article that compared "health care costs, quality-adjusted life years (QALYs), HIV prevalence, infections averted, and incremental cost-effectiveness" for interventions expanding methadone substitution therapy, increasing access to antiretroviral therapy, or a combination of the two. Based on their analysis, the authors report, "Offering methadone substitution therapy to 25% of IDUs reduced prevalence most effectively (to 53.1% IDUs, 0.80% non-IDUs), and was most cost-effective, averting 4,700 infections and adding 76,000 QALYs compared with no intervention at US$530/QALY gained" (Alistar et al., 3/1).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)